Lunai Bioworks Inc. Retained Earnings
Lunai Bioworks Inc. (LNAI) had Retained Earnings of -$512.01 million as of 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-05-15
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$512.01M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$509.44M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$507.64M.
- 2025-06-30: Retained Earnings (Accumulated Deficit) -$510.46M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-03-31 | -$512.01M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | -$509.44M 10-Q · filed 2026-02-17 | |
| 2025-09-30 | -$507.64M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | -$510.46M 10-Q · filed 2026-05-15 | |
| 2025-03-31 | -$383.73M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | -$383.92M 10-Q · filed 2025-02-19 | |
| 2024-09-30 | -$376.67M 10-Q/A · filed 2025-02-19 | -$368.89M 10-Q · filed 2024-11-14 |
| 2024-06-30 | -$332.46M 10-K · filed 2025-09-29 | -$324.68M 10-K · filed 2024-10-10 |
| 2024-03-31 | -$316.72M 10-Q/A · filed 2025-02-19 | -$274.76M 10-Q · filed 2024-05-15 |
| 2023-12-31 | -$257.73M 10-Q · filed 2024-02-14 | |
| 2023-09-30 | -$253.20M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | -$244.03M 10-Q/A · filed 2025-02-19 | |
| 2023-03-31 | -$220.83M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | -$216.50M 10-Q · filed 2023-03-09 | |
| 2022-09-30 | -$212.04M 10-Q · filed 2023-03-07 | |
| 2022-06-30 | -$204.35M 10-K · filed 2023-10-02 | |
| 2022-03-31 | -$114.11M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | -$107.91M 10-Q · filed 2022-02-14 | |
| 2021-09-30 | -$101.32M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | -$90.91M 10-K · filed 2023-02-27 | |
| 2021-03-31 | -$73.55M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | -$69.52M 10-Q · filed 2021-02-16 | |
| 2020-09-30 | -$66.58M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | -$64.19M 10-K · filed 2021-09-24 | |
| 2020-03-31 | -$60.09M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | -$58.58M 10-Q · filed 2020-02-10 | |
| 2019-09-30 | -$56.86M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | -$52.77M 10-K · filed 2020-09-23 | |
| 2019-03-31 | -$53.94M 10-Q · filed 2020-05-11 | -$62.60M 10-Q · filed 2019-05-16 |
| 2018-12-31 | -$51.21M 10-Q · filed 2020-02-10 | -$57.89M 10-Q · filed 2019-02-13 |
| 2018-09-30 | -$35.11M 10-Q · filed 2019-11-13 | -$39.90M 10-Q · filed 2018-11-14 |
| 2018-06-30 | -$34.76M 10-K · filed 2019-09-30 | -$37.60M 10-K · filed 2018-10-01 |
| 2018-03-31 | -$32.71M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | -$29.75M 10-Q · filed 2018-02-09 | |
| 2017-09-30 | -$28.67M 10-Q · filed 2017-11-20 | |
| 2017-06-30 | -$28.44M 10-K · filed 2018-10-01 | -$28.69M 10-K · filed 2017-09-29 |
| 2017-03-31 | -$28.26M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | -$28.01M 10-Q · filed 2017-02-14 | |
| 2016-09-30 | -$27.09M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | -$26.30M 10-K · filed 2017-11-20 | |
| 2016-03-31 | -$25.55M 10-Q · filed 2016-05-13 | |
| 2015-12-31 | -$25.34M 10-Q · filed 2016-02-12 | |
| 2015-09-30 | -$24.92M 10-Q · filed 2015-11-13 | |
| 2015-06-30 | -$24.57M 10-K · filed 2016-09-28 | |
| 2015-03-31 | -$23.15M 10-Q · filed 2015-05-13 | |
| 2014-12-31 | -$21.89M 10-KT · filed 2015-09-28 | |
| 2014-09-30 | -$20.94M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | -$20.40M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | -$19.95M 10-Q · filed 2014-05-14 | |
| 2013-12-31 | -$19.52M 10-KT · filed 2015-09-28 | |
| 2012-12-31 | -$17.37M 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |